A parent, desperate for reliable guidance on autism treatments for their child, turns to what should be the most trustworthy source in the nation—the Food and Drug Administration's website—only to find that a page once dedicated to warning against fraudulent and dangerous "cures" has
For a New Yorker diagnosed with a serious illness, the path to recovery is often overshadowed by the looming threat of financial ruin, a reality cemented by an outdated state law that has failed to keep pace with the modern cost of living. This is not a hypothetical scenario but the stark reality
A significant advancement in psychiatric medicine has emerged from the clinical pipeline, as a novel psilocybin-based compound demonstrated conclusive success in a pivotal late-stage trial for treatment-resistant depression. This development signals a potential paradigm shift, moving
A groundbreaking legislative proposal designed to shield Oregon’s medical facilities from federal immigration enforcement has ignited a fierce debate, placing the fundamental right to health care on a collision course with the authority of the U.S. government. The bill, a collaborative effort b
In a global healthcare landscape often characterized by a polarized debate between rapid deregulation and staunch prohibition, Switzerland has quietly cultivated a pragmatic third way for integrating novel therapeutics into its medical establishment. This approach, centered on medical cannabis,
With a rich background in developing the very medical technologies that shape diagnostics and treatment, Faisal Zain offers a unique, ground-level perspective on the grand challenges of healthcare policy. He has consistently championed innovation not just in the lab, but in the halls of government,
